SBFMW · Sunshine Biopharma, Inc.

Summary

Sunshine Biopharma, Inc. filed an 8-K on February 20, 2026, disclosing matters submitted to a vote of security holders under Item 5.07. Dr. Steve N. Slilaty, as the holder of the majority of the voting power of the stockholders, took action on February 18, 2026.

Key takeaways

• Filing date: 2026-02-20
• Item 5.07: Submission of Matters to a Vote of Security Holders
• Date of action: February 18, 2026
• Dr. Steve N. Slilaty holds majority of voting power